- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05913453
Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study
June 12, 2023 updated by: Carlo Fabbri, Azienda Unità Sanitaria Locale della Romagna
Among advanced resection techniques, endoscopic full thickness resection (EFTR) allows closure and full-thickness resection by the use of the non-exposed full thickness resection device (FTRD).
The study is a retrospective analysis of technical failure occurring during colorectal full-thickness resection.
Full thickness resection is a safe and effective procedure for "difficult" colorectal lesions.
However, technical failure can occur and to date there is no evidence about type and clinical consequences in this setting.
Study Overview
Status
Completed
Detailed Description
The study is a multicentre retrospective study involving centres with experience in advanced colorectal resections.
Each centre is invited to submit information about the Centre and to report alle the consecutive cases corresponding to technical failure.
Study Type
Observational
Enrollment (Actual)
77
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Forlì-Cesena
-
Forlì, Forlì-Cesena, Italy
- Ospedale Morgagni-Pierantoni
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing colorectal EFTR with occurrence of technical failure.
Description
Inclusion Criteria:
- Consecutive colorectal EFTR procedures with technical failure by using OVESCO Full Thickness Resection Device
Exclusion Criteria:
- EFTR performed by exposed techniques and/or devices different from FTRD
- Patients not able to give informed consent for data collection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Procedures corresponding to technical failure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Technical failure rate and classification
Time Frame: 2014 - 2022
|
2014 - 2022
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conservative Management of technical failure
Time Frame: 2014-2022
|
Performance of rescue endoscopic resection
|
2014-2022
|
|
Clinical success (R0 resection)
Time Frame: 2014-2022
|
2014-2022
|
|
|
Complication rate
Time Frame: 2014-2022
|
2014-2022
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2022
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
January 31, 2023
Study Registration Dates
First Submitted
March 24, 2023
First Submitted That Met QC Criteria
June 12, 2023
First Posted (Actual)
June 22, 2023
Study Record Updates
Last Update Posted (Actual)
June 22, 2023
Last Update Submitted That Met QC Criteria
June 12, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2993
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Individual Participant Data require data about experience in colorectal resections and EFTR; each centre will provide details for each technical failure including demographics, lesions characteristics, intraprocedural details and post-procedure outcomes.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Adenoma
-
Nanjing First Hospital, Nanjing Medical UniversityKunshan Hospital of Traditional Chinese Medicine; Jiangsu Province Hospital... and other collaboratorsNot yet recruiting
-
Fudan UniversityNot yet recruiting
-
Fudan UniversityNot yet recruiting
-
Fudan UniversityCompleted
-
National Cancer Institute (NCI)Active, not recruitingColorectal Adenoma | Colorectal Carcinoma | Colorectal Tubulovillous Adenoma | Colorectal Conventional Adenoma With Severe DysplasiaUnited States, Puerto Rico
-
Bundang CHA HospitalNot yet recruitingColorectal Adenoma | Colorectal Cancer Precancerous LesionSouth Korea
-
The Affiliated Hospital of Qingdao UniversityPeking University People's Hospital; Cancer Institute and Hospital, Chinese... and other collaboratorsRecruitingProbiotics | Colorectal AdenomaChina
-
Hospital Sirio-LibanesCompletedColorectal Cancer | Colonoscopy | Adenoma Detection Rate | Adenoma Colon | Colorectal Polyp | Sessile Serrated Adenoma | Quality IndicatorBrazil
-
University of DundeeCompletedColorectal Cancer | Colorectal AdenomaUnited Kingdom
-
Shandong UniversityCompletedColorectal Cancer | Colorectal AdenomaChina